WebJun 9, 2014 · /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company focused on the discovery, development, manufacture and sale... WebAug 11, 2024 · SAN DIEGO, Aug. 11, 2024 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (NASDAQ: SRNE; “Sorrento”), a clinical stage biopharmaceutical company developing new therapies to treat cancer, pain and COVID-19, and Dyadic International, Inc. (NASDAQ: DYAI; “Dyadic”), a global biotechnology company focused …
Dyadic International Inc
WebNov 8, 2024 · Latest News March 17, 2024 Vaxart to Host Webcast with Key Opinion Leaders to Discuss the Health Impact and Disease Burden for Norovirus March 15, 2024 Vaxart Provides Business Update and Full Year 2024 Financial Results March 08, 2024 Vaxart to Host Full Year 2024 Business Update and Financial Results Conference Call … WebMay 13, 2024 · Dyadic International, Inc. Ping W. Rawson Chief Financial Officer Phone: (561) 743-8333 Email: [email protected] DYADIC INTERNATIONAL, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS crypto root word meaning
Dyadic Reports First Quarter 2024 Financial Results and
WebDyadic International, Inc., a global biotechnology company focused on further improving, applying and deploying its proprietary C1-cell protein production platform to accelerate … WebMar 30, 2024 · Advancing Dyadic's proprietary COVID-19 vaccine candidate, DYAI-100, ... of the webcast will be available within 24 hours after completion of the live event and will be accessible on the Investor Relations section of the Company's website at www.dyadic.com for a limited time. To access the replay of the webcast, please follow the webcast link ... WebDYADIC INTERNATIONAL, INC. (Exact name of registrant as specified in its charter) Delaware 45-0486747 (State or other jurisdiction of incorporation or organization) (I.R.S. … crypto rotation